Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
9.15B | 7.10B | 6.62B | 6.29B | 5.37B | 5.18B | Gross Profit |
2.93B | 3.42B | 3.17B | 2.98B | 2.52B | 2.55B | EBIT |
2.24B | 1.69B | 1.26B | 1.42B | 1.18B | 1.19B | EBITDA |
3.12B | 2.40B | 1.98B | 2.25B | 1.77B | 1.60B | Net Income Common Stockholders |
1.50B | 1.20B | 770.00M | 1.17B | 803.00M | 675.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
321.00M | 321.00M | 209.00M | 186.00M | 200.00M | 294.00M | Total Assets |
11.71B | 11.71B | 10.86B | 10.89B | 10.07B | 8.90B | Total Debt |
4.27B | 4.27B | 4.10B | 4.10B | 4.34B | 4.41B | Net Debt |
3.95B | 3.95B | 3.90B | 3.92B | 4.16B | 4.14B | Total Liabilities |
7.04B | 7.04B | 6.90B | 6.89B | 6.95B | 6.62B | Stockholders Equity |
4.63B | 4.63B | 3.93B | 3.97B | 3.08B | 2.27B |
Cash Flow | Free Cash Flow | ||||
2.31B | 1.11B | 1.09B | 1.29B | 1.07B | 769.00M | Operating Cash Flow |
2.36B | 1.75B | 1.72B | 1.80B | 1.49B | 1.26B | Investing Cash Flow |
-1.98B | -1.10B | -948.00M | -1.12B | -827.00M | -1.18B | Financing Cash Flow |
-258.50M | -551.00M | -722.00M | -687.00M | -747.00M | 61.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $15.78B | 59.80 | 6.91% | 0.50% | 9.20% | ― | |
64 Neutral | $41.99B | 35.87 | 26.60% | 1.19% | 7.93% | 14.86% | |
64 Neutral | $41.80B | 44.79 | 463.98% | 0.52% | 7.47% | 59.46% | |
63 Neutral | $31.00B | 52.66 | 12.95% | 0.61% | 7.90% | 10.00% | |
63 Neutral | $41.40B | 77.81 | -47.82% | ― | 14.49% | 21.85% | |
62 Neutral | $8.11B | 13.34 | 1.17% | 3.02% | 4.16% | -15.14% | |
61 Neutral | $3.71B | ― | -0.85% | 2.27% | 2.93% | 39.49% |